MADELEY PRACTICE — All Prescriptions & Medications — Page 2
Practice Code: M83015 | CREWE, CW3 9NQ
Showing results 51-100 of 591
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Citalopram hydrobromide | 968 | 28.6K | £667 | -45.7% ▼ |
| Glucose blood testing reagents | 868 | 71.5K | £12.0K | +10.0% ▲ |
| Alogliptin | 850 | 23.0K | £20.4K | +235.2% ▲ |
| Venlafaxine | 838 | 31.9K | £5.7K | -0.8% vs avg |
| Doxycycline hyclate | 838 | 10.2K | £1.0K | +63.5% ▲ |
| Naproxen | 808 | 49.7K | £1.9K | -18.2% ▼ |
| Tramadol hydrochloride | 806 | 72.6K | £4.1K | +12.5% ▲ |
| Other emollient preparations | 803 | 417.5K | £5.5K | +33.7% ▲ |
| Codeine phosphate | 790 | 72.9K | £2.5K | +10.0% ▲ |
| Isosorbide mononitrate | 779 | 21.9K | £4.5K | +17.9% ▲ |
| Famotidine | 770 | 20.5K | £12.5K | +57.8% ▲ |
| Duloxetine hydrochloride | 761 | 29.2K | £2.0K | +19.7% ▲ |
| Ferrous fumarate | 753 | 26.9K | £1.2K | +3.9% ▲ |
| Solifenacin | 721 | 20.3K | £989 | +51.1% ▲ |
| 718 | 379.0K | £4.3K | -27.0% ▼ | |
| 704 | 1,369 | £47.4K | +29.2% ▲ | |
| Senna | 675 | 33.3K | £740 | +12.2% ▲ |
| Digoxin | 670 | 17.1K | £1.3K | +77.0% ▲ |
| Indapamide | 668 | 18.2K | £1.0K | -22.5% ▼ |
| Diazepam | 630 | 15.5K | £348 | +26.5% ▲ |
| Rivaroxaban | 615 | 16.8K | £10.9K | +0.5% vs avg |
| Ibuprofen | 614 | 60.3K | £2.2K | +20.7% ▲ |
| Atenolol | 609 | 17.8K | £403 | +1.0% vs avg |
| Fluticasone propionate (Inhalation) | 608 | 623 | £16.1K | +57.1% ▲ |
| Buprenorphine | 601 | 2,404 | £12.8K | +64.1% ▲ |
| Betamethasone valerate | 597 | 39.0K | £3.3K | +55.1% ▲ |
| Trimethoprim | 590 | 11.6K | £871 | +188.7% ▲ |
| Mometasone furoate | 590 | 593 | £4.6K | +47.0% ▲ |
| Hydrocortisone | 581 | 17.0K | £2.6K | +29.6% ▲ |
| Cyanocobalamin | 580 | 25.2K | £2.8K | +64.3% ▲ |
| Morphine sulfate | 569 | 83.4K | £3.9K | -13.2% ▼ |
| Sildenafil (Erectile Dysfunction) | 569 | 3,712 | £535 | +12.9% ▲ |
| Budesonide | 548 | 1,346 | £15.9K | +1.1% vs avg |
| Flucloxacillin sodium | 548 | 20.4K | £1.2K | +21.9% ▲ |
| Alginic acid compound preparations | 536 | 245.4K | £3.7K | -8.5% ▼ |
| Nitrofurantoin | 530 | 4,812 | £3.1K | +11.1% ▲ |
| Perindopril erbumine | 514 | 15.9K | £1.2K | -3.2% ▼ |
| Memantine hydrochloride | 505 | 13.2K | £1.3K | +52.9% ▲ |
| Bendroflumethiazide | 493 | 14.1K | £236 | -36.3% ▼ |
| Zopiclone | 490 | 10.3K | £428 | -11.5% ▼ |
| Spironolactone | 489 | 12.8K | £3.4K | -9.3% ▼ |
| Edoxaban | 489 | 13.5K | £21.7K | -30.2% ▼ |
| Linagliptin | 480 | 11.4K | £12.6K | +17.2% ▲ |
| Insulin aspart | 473 | 2,767 | £16.6K | +24.2% ▲ |
| Latanoprost | 464 | 6,168 | £2.1K | -4.4% ▼ |
| Estradiol | 462 | 125.2K | £15.0K | -43.7% ▼ |
| Lamotrigine | 443 | 26.0K | £6.3K | -25.0% ▼ |
| Diltiazem hydrochloride | 437 | 17.6K | £3.5K | +42.3% ▲ |
| Mirabegron | 437 | 10.6K | £9.4K | +8.8% ▲ |
| Co-careldopa (Carbidopa/levodopa) | 432 | 35.4K | £2.3K | +91.2% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.